CCL2 and central nervous system cancer: CCL2 was significantly down-regulated after SU4312 treatment, and the number of M2 macrophages was subsequently decreased, indicating that the effect of SU4312 on the glioma-immune microenvironment is mediated by the down-regulation of CCL2.